Research
The goal of our research analysts is to provide institutional investor clients with timely, insightful and useful research and investment strategies. Members of the research team pride themselves on their ability to identify compelling investment opportunities for our clients by discovering high-quality, undervalued companies before they are recognized by the market at large. Our analysts’ in-depth expertise in their areas of specialization and their strong industry relationships enable them to be at the forefront of the market trends impacting the companies they follow. By clearly and effectively presenting their investment theses and expectations for both performance and risk, our research professionals help investors make sound decisions in today’s volatile markets.
Rodman’s analysts have consistently been recognized as industry leaders. Most recently The Wall Street Journal recognized Senior Biotechnology analysts Elemer Piros, PhD, Thomas Shrader, PhD and Navdeep Jaikaria, PhD, ranking them # 1, # 3 and # 5 among biotech analysts in the 2007 Best on the Street survey.
